Uranium stocks Boss Energy (ASX: BOE) and Paladin Energy (ASX: PDN) have struggled despite a generally positive long-term outlook for the uranium market. This reflects the impact of production adjustments and supply constraints. The fortunes of both companies remain closely tied to uranium prices, which have recently experienced volatility.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
BOE and PDN Price Targets
Both BOE and PDN share prices have seen significant corrections since peaking early last year. Boss Energy is currently trading approximately 67% below its peak, while Paladin Energy is down around 55%. These declines reflect, in part, a broader correction in the uranium spot price, which after reaching US$110/lb, dipped into the low $60s before recovering to around US$76/lb.
The recent rebound in uranium stocks has been spurred by updates from major producers Cameco (TSX: CC0) and Kazatomprom (LSE: KAP). Cameco trimmed its 2025 production guidance for the McArthur River mine by approximately 3.5 million pounds, citing development delays and technical issues. Kazatomprom declined to provide a specific target range for 2026 production, indicating it would exercise a 20% “downflex” option due to constrained acid supply and logistical bottlenecks. The company also highlighted a roughly 10% decrease in subsoil use agreement (SUA) levels for 2026, effectively capping its maximum output.
According to a research note by Morgan Stanley, Cameco’s reduced guidance will increase the forecast uranium market deficit in 2025 to 14 million pounds from 10 million pounds. Canaccord Genuity interpreted Kazatomprom’s decision as a sign of deep uncertainty, writing that “the actual production outcome is dependent on (constrained) acid supply and alleviation of other logistical constraints.”
UBS has adjusted its outlook for both Boss Energy and Paladin Energy, maintaining “Buy” ratings but lowering price targets due to revised uranium price forecasts. The price target for Paladin Energy is set at $9.90 per share, down from $10.40, while Boss Energy’s target is $3.40, reduced from $3.50. UBS believes that recent share price declines may be overdone and that operational challenges are being addressed.
Uranium Supply & Demand Factors
Supply-side factors influencing the uranium stocks include acid shortages in Kazakhstan, where Kazatomprom relies heavily on acid for in-situ recovery processes. Canaccord reported that Kazatomprom’s “domestic acid production has slowed since Q1”, with year-to-date output up just 4% compared with last year after a strong start. Operational issues and production delays at key projects like Budenovskoye and McArthur River are also impacting supply. Citi noted that there is a “significant risk for balances” and will almost certainly create upside pressure on the uranium price given the lack of any new mine development that would result in “meaningful uranium supply in the next five years.”
On the demand side, the Sprott Physical Uranium Trust continues to purchase uranium, removing pounds from the market. Morgan Stanley reported that Sprott has purchased 2.3 million pounds of uranium since June. Regulatory frameworks are also becoming more constructive, with President Trump having signed four executive orders under the Defense Production Act to “aggressively scale US nuclear energy, positioning it as a national security priority,” according to Citi.
Uranium Price Drivers
Global reactor development, particularly in China, remains a key driver of long-term growth for uranium stocks. Citi estimates Chinese utilities will consume 35 million pounds of uranium in 2025, rising to 58 million pounds by 2030. Small modular reactors (SMRs) and enrichment overfeeding could also significantly reshape demand balances, with Citi forecasting around 25 SMR projects will be commercialized globally before 2035.
Recent news events highlight these dynamics. Kazatomprom’s challenges securing sufficient sulfuric acid led to a 10% reduction in its 2024 production guidance, contributing to uranium prices reaching 17-year highs. Cameco temporarily suspended production at its Inkai joint venture in Kazakhstan due to regulatory approval delays. The World Nuclear Association warns of a potential uranium supply shortfall, projecting global demand to increase significantly by 2040.
While uranium stocks will likely continue to respond to short-term production updates, the longer-term picture suggests a potential for upside. Acid shortages, operational delays, and a scarcity of new mines mean supply growth may struggle to keep pace with growing demand. As such, markets should remain aware that short-term turbulence will remain a feature, but the structural forces suggest that the long-term trajectory is likely skewed to the upside.
Don’t Buy Just Yet
You will want to see this before you make any decisions.
Before you decide which shares to add to your portfolio you might want to take a look at this special report we recently published.
Our experts picked out The 5 best ASX shares to buy in 2025.
We’re giving away this valuable research for FREE.
Click below to secure your copy
